Feb 13 (Reuters)-
D.Western Therapeutics Institute Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2022 Dec 31, 2021 Dec 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 411 mln 412 mln 400 mln
(-0.1 pct) (+23.2 pct) (-2.8 pct)
Operating loss 255 mln loss 56 mln
Recurring loss 241 mln loss 39 mln loss 1.33
Net loss 386 mln loss 240 mln loss 1.33
EPS loss 13.05 yen loss 8.21 yen loss 42.67 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T